Skip to main content
TipRanks
Go Ultimate75% OFF

Mangalam Organics Ltd (MANORG) AI Stock Analysis

0 Followers
IN:MANORG

Mangalam Organics Ltd

(NSE:MANORG)

Select Model
Rating:48Neutral
Price Target:INR 428.00â–¼(-0.90% Downside)
Action:reiterated
Date:09/06/26

The overall score is constrained by significant financial risks, primarily high leverage and negative cash flows, which overshadow improving profitability. Technicals are neutral, and valuation is fair but offers no catalyst. The company's turnaround is not yet reflected in its cash generation or balance sheet strength.

Positive Factors
Steady Revenue GrowthSteady revenue growth indicates continued demand for the company’s products and improving commercial scale. If maintained, this expansion can support better operating leverage, broaden customer penetration, and provide a durable base for rebuilding profitability over the next several quarters.
Negative Factors
materially Higher LeverageThe sharp increase in debt relative to equity raises financial risk and reduces flexibility if operating conditions weaken. Greater leverage can absorb more future cash flow through financing obligations, limiting the company’s ability to fund growth or withstand another earnings downturn.

Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%30%40%IN:MANORG-4.98%INDA-5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 3.76B
Dividend Yield
―
Average Volume (3M)
559
Price to Earnings (P/E)
18.2
Beta (1Y)
1.06
Revenue Growth
17.28%
EPS Growth
-10.19%
Country
India
Employees
347
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Mangalam Organics Ltd Business Overview & Revenue Model

Company Description

Mangalam Organics Limited, together with its subsidiaries, manufactures and sells chemicals for the industrial and consumer markets in India and internationally. The company offers terpene products, including camphor, camphene, dipentene, isobornyl a...

Mangalam Organics Ltd Financial Statement Overview

Summary

Financial performance is mixed. The Income Statement shows recovery with moderate revenue growth and a healthy gross margin, but the Balance Sheet is highly leveraged (debt-to-equity > 1.0) and Cash Flow is deeply negative, indicating significant financial risk and weak cash conversion.

Income Statement

58Neutral

Balance Sheet

42Neutral

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue6.55B6.23B5.30B4.94B4.93B4.91B
Gross Profit2.42B2.17B2.57B1.13B701.20M1.47B
EBITDA857.00M890.69M589.13M390.38M-24.27M924.25M
Net Income207.96M257.56M125.97M42.86M-272.25M537.43M
Balance Sheet
Total Assets07.40B6.24B4.85B5.06B5.60B
Cash, Cash Equivalents and Short-Term Investments25.91M24.68M189.27M20.19M12.79M12.78M
Total Debt03.59B2.72B1.73B1.90B2.12B
Total Liabilities-3.19B4.21B3.30B2.05B2.30B2.56B
Stockholders Equity3.19B3.19B2.93B2.81B2.76B3.04B
Cash Flow
Free Cash Flow-769.42M-907.41M-751.15M327.48M361.57M-1.84B
Operating Cash Flow-281.34M-272.47M-78.44M727.23M769.23M-841.04M
Investing Cash Flow-381.05M-600.78M-670.47M-395.09M-407.80M-995.25M
Financing Cash Flow673.44M879.76M736.26M-325.52M-355.77M1.83B

Mangalam Organics Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price431.90

Price Trends

50DMA453.37Negative
100DMA482.60Negative
200DMA474.21Negative

Market Momentum

MACD-3.51Positive
RSI42.10Neutral
STOCH44.83Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Negative. The current price of 431.90 is below the 20-day moving average (MA) of 453.05, below the 50-day MA of 453.37, and below the 200-day MA of 474.21, indicating a bearish trend. The MACD of -3.51 indicates Positive momentum. The RSI at 42.10 is Neutral, neither overbought nor oversold. The STOCH value of 44.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MANORG.

Mangalam Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:MANORG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:JAYAGROGNIN:JAYAGROGN67NeutralINR 7.21B10.94―1.46%18.12%27.74%
IN:ROSSARIIN:ROSSARI65NeutralINR 23.61B15.49―0.12%19.76%11.74%
IN:CHEMCONIN:CHEMCON61NeutralINR 7.26B24.44―3.27%22.25%20.33%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:FAIRCHEMORIN:FAIRCHEMOR53NeutralINR 8.32B35.00―0.15%17.44%304.08%
IN:MANORGIN:MANORG48NeutralINR 3.70B18.20――17.28%-10.19%
IN:AARTISURFIN:AARTISURF46NeutralINR 4.92B26.83―0.17%35.30%95.10%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%IN:MANORGIN:AARTISURFIN:CHEMCONIN:FAIRCHEMORIN:JAYAGROGNIN:ROSSARIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:MANORG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:MANORGMangalam Organics Ltd431.90-15.60-3.49%
IN:AARTISURFAarti Surfactants Ltd.581.10131.3329.20%
IN:CHEMCONChemcon Speciality Chemicals Ltd198.30-24.53-11.01%
IN:FAIRCHEMORFairchem Organics Ltd660.25-36.30-5.21%
IN:JAYAGROGNJayant Agro-Organics Limited240.4025.4911.86%
IN:ROSSARIRossari Biotech Ltd426.25-195.30-31.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026